Dave has worked with the partners of Solas BioVentures Fund since 2004 and was a founding member of the fund in 2014. He currently focuses on investments in medical device and therapeutic companies. Board certified in Maternal-Fetal Medicine, Obstetrics and Gynecology, and Hypertension, with special expertise in Critical Care, Dave is a long-time physician, educator, administrator, innovator, and biotech/med-tech investor with nearly 20 years of experience in angel and venture investing. Dave recently retired from his position as Professor and Vice Chairman of the Department of Obstetrics and Gynecology at the University of Tennessee College of Medicine. Dave also retired from clinical practice after a 30 year career. Dave received a BS in Biology from Morehead State University, where he is Hall of Fame member, is a recent graduate from University Tennessee Chattanooga with his Master of Business Administration with a concentration in Healthcare and earned his medical degree from the Joan C. Edwards College of Medicine at Marshall University in 1990. He completed residency at the University of Florida Health Science Center and Fellowship training at Wake Forest University.
DAVID ADAIR, MD, MBA
Co-Founder & Managing Director
MARK HACKETT, JD
Co-Founder & Managing Director
Mark is an attorney who has spent nearly 20 years practicing extensively in the life sciences and corporate law areas, including serving over 10 years as General Counsel to a biopharma and medtech company specializing in pregnancy health. Mark has handled a wide range of life science matters, including company financing, investor representation, M&A, strategic alliances, technology licensing, regulatory, IP strategy, and clinical, manufacturing and distribution contracting. Mark earned his B.A. from Tulane University and his J.D. from Vanderbilt University School of Law. Formerly a partner at a large, national law firm, Mark co-founded Evans Harrison Hackett PLLC in 2007, where he serves as managing partner. After managing several successful angel group investments, Mark and Dave teamed up with Casey to form Solas BioVentures Fund I in 2014.
Casey focuses on evaluating potential investments, financial analysis, due diligence and portfolio management. He also leads the Fund’s operational and administrative functions. He began his career as an analyst at Wellington Management Company, LLC. He joined Resolute Capital Partners’ predecessor at its inception in 2005, became a partner in 2007, and has been actively involved in each of its funds. Casey earned a Bachelor of Science in Business Administration degree from East Tennessee State University, an MBA from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill. Casey also earned the Chartered Financial Analyst designation in 2003.
CASEY HAMMONTREE, MBA, MBEE
Co-Founder & General Partner
MICHAEL HOEY, PHD, MBA
Michael is a serial entrepreneur, founding eight medical products companies, one agricultural company, and one musical products company. Prior to that he taught and performed research at the University of Minnesota Medical School, the College of Engineering Sciences, and the Carlson School of Management. Professor Hoey also taught in the School of Biological Sciences at Hamline University in St. Paul, Minnesota. Michael was also Executive Chairman of a financial institution that he directed from $150M to more than $2.5B. Michael is a prolific inventor with over 200 patents granted and/or applied for. Collectively, the start-up medical companies he has been involved in raised $400 million of capital. Four of those companies combined have harvested greater than $1.5B and two more are commercializing product. He also harvested the musical company, and the agricultural company is in commercialization.
Joshua Eckelberry graduated with honors from East Tennessee State University with a BS in Biochemistry as a Mayme Frazier Scholar and then attended Quillen College of Medicine for two years on the nationally ranked rural health track before diverting to pursue an MBA in Healthcare Administration. While in school he pioneered Quillen's anatomy lab internship where he helped create the school's first digital dissector, served as president of the local American Medical School Association, helped negotiated a hospital staffing contract worth over $1M, and raised over $200K for area non-profit clinics. With his understanding of both the science and business sides of the life science industry, Josh helps translate and negotiate the optimal outcome for patients and the companies. Josh has a lifelong commitment to drive positive impact on the community and the world through leveraged change.
JOSHUA ECKELBERRY, MBA
Jackson Davis graduated from Vanderbilt University with a Bachelor of Arts in Economics and Corporate Strategy. He spent a year abroad between the London Executive Business Program, studying International Business, and the University of Oxford, Christ Church, studying Economics and Law. During his undergrad, Jackson worked in business development, investments, and innovation consulting with the United States Olympic Committee, the Dow Jones, the Tennessee Treasury, J.P. Morgan, and Accenture. After graduating, Jackson moved to Chattanooga, TN to be the first Fellow, and GIGTANK Program Manager, at The Company Lab. Next, Jackson worked as a Venture Associate, managing sourcing and fundraising, for Techstars Atlanta, backed by Cox Enterprises.